21987 Investors following Glenmark. Share this News with them.
0
Like this story, share it with millions of investors on M3
Glenmark Q1 net profit seen up at Rs 141.2 cr: Religare
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Glenmark Pharma's June quarter sales are expected to go up by 24.8% to Rs 574.6 crore on YoY basis.
Religare Hichens Harrison Research has come out with its earning estimates on Pharmaceutical Sector for the quarter ended June 2009. According to the research firm, Glenmark Pharma 's June quarter sales are expected to go up by 24.8% to Rs 574.6 crore on YoY basis.
The company's net profit is expected to go up by 22.9% to Rs 141.2 crore on YoY basis.